Korean J Anesthesiol.  2000 May;38(5):855-862. 10.4097/kjae.2000.38.5.855.

The Effect of 4-Aminopyridine with Anticholinesterases on MgSO4-Rocuronium-Induced Neuromuscular Blockade in Vitro

Affiliations
  • 1Department of Anesthesiology, College of Medicine, Soon Chun Hyang University, Seoul, Korea.

Abstract

BACKGROUND: The aim of this study was to evaluate the effect of 4-aminopyridine (4-AP) combined with anticholiesterase (antiChE) in antagonizing MgSO4-rocuronium-induced neuromuscualr blockade using a rat hemidiaphragm.
METHODS
A hemidiaphragm with phrenic nerve was dissected and was mounted in a bath containing oxygenated Krebs solution. The phrenic nerve was stimulated supramaximally and the twitch response (0.1 Hz) was stabilized for at least 30 minutes. After maximal twitch inhibition by IC95 (concentration of 95% twitch inhibition) of rocuronium and MgSO4 20 mg was achieved, antagonistic effects of 1.6, 16 microgram/ml of edrophonium, 0.1, 1.0 microgram/ml of neostigmine, 0.5, 5.0 microgram/ml of pyridostigmine, and 0.8 microgram/ml of 4-AP combined with each of the above mentioned antiChEs were investigated.
RESULTS
Whereas antiChE alone at low concentration partially recovered only the twitch response, 4-AP combined with antiChE recovered both the twitch and train-of-four responses significantly.
CONCLUSIONS
4-AP enhances antagonism of a magnesium-rocuronium induced neuromuscular blockade by edrophonium, neostigmine or pyridostigmine in vitro.

Keyword

Antagosnist, neuromuscular relaxants: 4-aminopyridine; edrophonium; neostigmine; pyridostigmine; Interaction, drug: magnesium sulfate; rocuronium

MeSH Terms

4-Aminopyridine*
Animals
Baths
Cholinesterase Inhibitors*
Edrophonium
Neostigmine
Neuromuscular Blockade*
Oxygen
Phrenic Nerve
Pyridostigmine Bromide
Rats
4-Aminopyridine
Cholinesterase Inhibitors
Edrophonium
Neostigmine
Oxygen
Pyridostigmine Bromide
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr